What is the interpretation of a Forced Vital Capacity (FVC) of 47%, Forced Expiratory Volume in one second (FEV1) to Forced Vital Capacity (FVC) ratio of 78%, and Forced Expiratory Volume (FEV) of 59%?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: May 10, 2025View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

From the Guidelines

The pulmonary function test results indicate a restrictive lung disease pattern, with an FVC of 47% predicted and an FEV1 of 59% predicted, suggesting moderate to severe restriction 1. The FVC is significantly reduced, indicating a limitation in lung expansion or chest wall movement. The FEV1/FVC ratio is normal at 78%, which differentiates this pattern from obstructive lung disease 1. According to the severity classification based on FEV1 % predicted 1, an FEV1 of 59% predicted falls into the moderately severe category. This restrictive pattern may be associated with conditions such as interstitial lung disease, pulmonary fibrosis, neuromuscular disorders, pleural disease, obesity, or chest wall deformities 1. Further evaluation, including a complete clinical assessment, chest imaging (typically high-resolution CT scan), and possibly additional tests like diffusion capacity (DLCO), is necessary to determine the specific cause of restriction 1. Treatment should focus on addressing the underlying cause, which may include anti-inflammatory medications, antifibrotics for pulmonary fibrosis, or management of underlying conditions 1. The reduced lung volumes likely cause significant symptoms like shortness of breath, especially with exertion, and impact the patient's quality of life 1. It is essential to follow the recommendations for a standardized pulmonary function report, including the presentation of FVC, FEV1, and FEV1/FVC, to ensure accurate interpretation and clinical application 1.

From the Research

Interpretation of Pulmonary Function Test Results

The given pulmonary function test results are:

  • FVC: 47
  • FEV1/FVC: 78
  • FEV1: 59

Obstructive or Restrictive Pattern

According to the study 2, an obstructive defect is indicated by a low FEV1/FVC ratio, which is defined as less than 70% or below the fifth percentile based on data from the Third National Health and Nutrition Examination Survey (NHANES III) in adults. In this case, the FEV1/FVC ratio is 78, which is above 70%. However, the FEV1 is 59, which may indicate an obstructive pattern, but the FEV1/FVC ratio suggests otherwise.

Severity of the Abnormality

The study 2 states that the severity of the abnormality is determined by the FEV1 (percentage of predicted). However, without the percentage of predicted FEV1, it is difficult to determine the severity of the abnormality.

Mixed Defect

If both the FEV1/FVC ratio and the FVC are low, the patient has a mixed defect. In this case, the FVC is 47, which is low, and the FEV1/FVC ratio is 78, which is not low. Therefore, it is not a clear mixed defect.

Key Points to Consider

  • The FEV1/FVC ratio is above 70%, which suggests that there is no obstructive defect.
  • The FVC is low, which may indicate a restrictive pattern.
  • The FEV1 is low, which may indicate an obstructive pattern, but the FEV1/FVC ratio suggests otherwise.
  • Without the percentage of predicted FEV1, it is difficult to determine the severity of the abnormality.

Further Evaluation

According to the study 2, if a restrictive pattern is present, full pulmonary function tests with diffusing capacity of the lung for carbon monoxide testing should be ordered to confirm restrictive lung disease and form a differential diagnosis.

Some studies 3, 4, 5, 6 discuss the diagnosis and management of chronic obstructive pulmonary disease (COPD) and asthma, but they do not provide direct evidence to interpret the given pulmonary function test results.

References

Guideline

Guideline Directed Topic Overview

Dr.Oracle Medical Advisory Board & Editors, 2025

Research

FEV1/FVC Severity Stages for Chronic Obstructive Pulmonary Disease.

American journal of respiratory and critical care medicine, 2023

Research

Salmeterol-Fluticasone: The Role Revisited.

The Journal of the Association of Physicians of India, 2022

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.